N/a
-Catalyst Biosciences Announces Global License and Collaboration Agreement to Develop Pegylated CB 2782 for the Treatment of Dry Age-Related Macular Degeneration
-2018 S-3 for $200m / none of it used so far
-Levels: 6.7, 7.1, 7.50, 8.20
-Swing neck line: 7.10
-Swing Death line: 6
-Setting up for nice POC relief trade if it gaps down on Monday
First Test long of 7.40
Decided to cut trade early as it wasn't bouncing. ended up trading lower to 7.30 but then bouncing almost 30c. The First bounce actually would have hit my target fantasy orders but I cut it before I got filled due to weakness on the tape.
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2019-12-20 11:27:13 | CBIO | buy | $7.440 | long |
2019-12-20 11:27:13 | CBIO | buy | $7.420 | long |
2019-12-20 11:28:04 | CBIO | sell | $7.450 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!